8BCRP/ ABCG2 in the Placenta: Expression, Function and Regulation
2005 - 2007
On The Rate and Extent of Drug Delivery to the Brain. DEC 2007.
RNAi for Treating Hepatitis B Viral Infection. DEC 2007.
In Vivo Methods for the Assessment of Topical Drug Bioavailability. NOV 2007.
Pharmaceutical Particle Engineering via Spray Drying. NOV 2007.
Nonviral Approaches for Neuronal Delivery of Nucleic Acids. OCT 2007.
Multifunctional Nanoparticulate Polyelectrolyte. OCT 2007.
Immune Cell Recruitment and Cell-Based System for Cancer Therapy. SEPT 2007.
Designer Gene Delivery Vectors: Molecular Engineering and Evolution of Adeno-Associated Viral Vectors for Enhanced Gene Transfer. SEPT 2007.
Natural and Synthetic Polymers as Inhibitors of Drug Efflux Pumps. SEPT 2007.
The Apoptosome: Emerging Insights and New Potential Targets for Drug Design. AUG 2007.
Contribution of Carrier-Mediated Transport Systems to the Blood–Brain Barrier as a Supporting and Protecting Interface for the Brain; Importance for CNS Drug Discovery and Development. JUL 2007.
Matrix Metalloproteinase Gene Delivery for Liver Fibrosis. JUN 2007.
Sheddable Coatings for Long-Circulating Nanoparticles. JUN 2007.
Polyspecific Organic Cation Transporters: Structure, Function, Physiological Roles, and Biopharmaceutical Implications. MAY 2007.
New Insights into the Pathogenesis and Treatment of Idiopathic Pulmonary Fibrosis: A Potential Role for Stem Cells in the Lung Parenchyma and Implications for Therapy. MAY 2007.
Cell Penetrating Peptides: Intracellular Pathways and Pharmaceutical Perspectives. APR 2007.
Poly(ethylene glycol)-modified Nanocarriers for Tumor-targeted and Intracellular Delivery. MAR 2007.
Cell and Tissue Targeting of Nucleic Acids for Cancer Gene Therapy. MAR 2007.
New Insights into the Pathogenesis and Treatment of Idiopathic Pulmonary Fibrosis: A Potential Role for Stem Cells in the Lung Parenchyma and Implications for Therapy. MAR 2007.
A Cheminformatic Toolkit for Mining Biomedical Knowledge. MAR 2007.
The Evolving Role of Drug Metabolism in Drug Discovery and Development. MAR 2007.
Encapsulation of Nucleic Acids and Opportunities for Cancer Treatment. FEB 2007.
Lipid-based Nanoparticles for Nucleic Acid Delivery. JAN 2007.
Organic Anion Transporters of the SLC22 Family: Biopharmaceutical, Physiological, and Pathological. JAN 2007.
Particle Engineering for Pulmonary Drug Delivery. JAN 2007.
Influence of Drug Transporter Polymorphisms on Pravastatin Pharmacokinetics in Humans. DEC 2006.
Molecular Insights into the Structure–Function Relationship of Organic Anion Transporters OATs. NOV 2006.
Antiplatelet Drug Resistance and Drug-Drug Interactions: Role of Cytochrome P450 3A4. NOV 2006.
Analytical Tools and Approaches for Metabolite Identification in Early Drug Discovery. OCT 2006.
Pharmacokinetics and Pharmacodynamics of Nonsteroidal Androgen Receptor Ligands. JULY 2006.
Controlling Protein Compartmentalization to Overcome Disease. SEPT 2006.
Real-time Imaging and Quantification of Brain Delivery of Liposomes. SEPT 2006.
Protection Against Chemotherapy-Induced Alopecia. SEPT 2006.
Heterogeneity of Breast Cancer among Patients and Implications for Patient Selection for Adjuvant Chemotherapy. AUG 2006.
Toxicogenomics in Drug Discovery and Drug Development: Potential Applications and Future Challenges. JULY 2006.
Nanotechnology: intelligent design to treat complex disease. JUNE 2006.
CYP Induction-Mediated Drug Interactions: in Vitro Assessment and Clinical Implications. MAY 2006.
Application of Micro- and Nano-Electromechanical Devices to Drug Delivery. MAY 2006.
Metabonomics Techniques and Applications to Pharmaceutical Research & Development
Plasmid Engineering for Controlled and Sustained Gene Expression for Nonviral Gene Therapy. MAY 2006.
The Nuclear Pore Complex: The Gateway to Successful Nonviral Gene Delivery. MARCH 2006.
Advances in the Use of Tocols as Drug Delivery Vehicles. JAN 2006.
Facilitating Physiologic Self-Regeneration: A Step Beyond Islet Cell Replacement. JAN 2006.
Methods to Assess in vitro Drug Release from Injectable Polymeric Particulate Systems. JAN 2006.
Polymer Architecture and Drug Delivery. JAN 2006.
Apical/Basolateral Surface Expression of Drug Transporters and its Role in Vectorial Drug Transport. SEPT 2005.
Potential Role of Acyl-Coenzyme A:Cholesterol Transferase (ACAT) Inhibitors as Hypolipidemic and Antiatherosclerosis Drugs. SEPT 2005.
Bioanalytical Method Validation for Macromolecules in Support of Pharmacokinetic Studies. AUG 2005.
Friday, March 5, 2010
Posted by Dr. Vikas Anand Saharan at 1:28 PM